Your search for "press releases" return 17 results.
Terms and Conditions >
TERMS AND CONDITIONS OF SALE
CEVA EXPANDS ORAL RABIES VACCINE PORTFOLIO WITH THE ACQUISITION OF CANADIAN FIRM ARTEMIS TECHNOLOGIES, INC. >
Libourne, May 16, 2022 – Ceva Santé Animale (Ceva) has acquired the Canadian oral rabies vaccine manufacturer Artemis Technologies, Inc. Artemis, located in Guelph, ON, Canada, produces ONRAB®, a ra...
Ceva Animal Health Expands Donation Program to Support Hurricane Pet Relocations >
Ceva urges volunteers to follow new AHS “best practices” to help stop heartworm transmission via transported dogs.
Ceva Santé Animale confirms its circle of virtuous growth in 2016 >
2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m.
New Research Adds Support to Change Heartworm Protocol >
Phase 2 Study calls for fighting both the mosquito and the heartworm
Ceva Animal Health Receives Contract to Provide Avian Influenza Vaccine for USDA stockpile >
Ceva receives contract to produce avian influenza vaccine.
Craig Wallace named finalist for the EY Entrepreneur Of The Year® 2015 Award in the Central Midwest >
EY Entrepreneur Of The Year is the world’s most prestigious business award for entrepreneurs.
Ceva Animal Health Leases Space in Hunt Midwest SubTropolis >
Ceva leases 72,000 square feet of warehousing and distribution space in Hunt Midwest SubTropolis
Ceva Animal Health Introduces A New Tool in the Fight Against the Spread of Salmonella >
A new Salmonella vaccine will offer poultry producers a unique opportunity to strengthen their existing Salmonella prevention programs.
Sogeval to rename Tri-Cox; now TRP-Tri-COX >
In connection with a trademark infringement lawsuit brought by PSPC, Inc. against Sogeval Laboratories, Inc. in the United State District Court for the Middle District of Florida, the parties have ent...